Name: Diversity in Pharma: The Impact of COVID-19 on DE&I
Start: 2022-06-23T14:00:00Z
End: 2022-06-23T14:01:02.000Z
Location: BrightTALK
Rating: 5

Datateam is a modern and dynamic communications business with a comprehensive product portfolio of leading publications, websites and events across many business-to-business and healthcare sectors.

The Brighttalk Datateam webinar channel holds content from a wide variety of brands and business sectors.

In the face of budget cuts and rising costs, the public education sector is under unrelenting pressure to do more with less.

As Schools, Multi-Academy Trusts, and colleges look to save time and money, smart software offers opportunities to do just that. This means more resources can be put towards what matters most: education.

This webinar will explore:

• The unique challenges faced by schools, MATs, and colleges
• The potential for smart software to improve financial, operations and people management
• How schools can achieve financial resilience, a safer environment and more effective teams with the right technology behind them
• Smart software as a necessary foundation for smarter schools seeking to embrace digital transformation

Join Civica's Executive Director - Education, Stewart Mcluskey, and our panel of senior experts as they share their experiences and insights into the transformative power of smart software for the education sector.

Our panellists include:

• Lana Stoyles, Head of Business Transformation, Nexus MAT
• James Roach, CEO of Inclusive MAT
• Sharon Carlyon, COO of Inclusive MAT

Improving the financial and operational health of UK schools

With the flu season rapidly approaching, there is a surge in influenza and vaccine-related studies. These studies often face the significant challenge of a very short recruitment window, which necessitates thorough preparation and strategic planning during the design phase. Addressing these challenges early is crucial to the success of the studies.

Join us for an insightful webinar featuring experts from Innovative Trials and Parexel, where we will delve into the most common patient recruitment and retention issues encountered in influenza and flu vaccine studies. This session will provide a deep dive into the practical challenges faced during the recruitment process and offer innovative solutions to overcome these hurdles.

During this webinar, you will gain valuable insights into effective strategies for recruiting and retaining participants within the constrained timelines typical of flu studies. Our experts will share their experiences and best practices, highlighting real-world examples and case studies to illustrate successful approaches.

Don't miss the opportunity to engage in a live Q&A session, where you can discuss the specific challenges you are facing and receive personalized advice on how to tackle them. Whether you are a researcher, clinician, or involved in the operational aspects of clinical trials, this webinar will equip you with the knowledge and tools needed to enhance your study's success during the upcoming flu season.

Join us for this informative session and take the first step towards optimizing your influenza and vaccine studies.

Speakers:
Leanne Woehlke - Executive Vice President,  Soglia, a division of Entrada
Amber McAllister - Associate Director, Patient Recruitment, Parexel
Georgia Hardy - Senior Associate Director, Patient Recruitment, Innovative Trials 
Antonio Drea - Director, Strategic Accounts, TransPerfect

Optimizing Patient Recruitment & Retention in Influenza Studies

Join Inizio Evoke and Professor Georgina Charlesworth of University College London’s (UCL) Faculty of Brain Sciences for an unmissable discussion on our revolutionary new report, Transforming Bias in Healthcare. This webinar will delve into the hidden epidemic of bias in healthcare and its profound impact on patient outcomes, offering actionable insights to address this critical issue. “It’s no exaggeration to say that bias kills,” asserts Corrina Safeio, President of Inizio Evoke. With alarming statistics suggesting that a million premature deaths in the UK over the last decade are linked to health inequality, the urgency of this research cannot be overstated. Our report, the first global systematic review of healthcare professional (HCP) bias, uniquely, for the first time, measures the impact on patient outcomes.  Led by our esteemed behavioural science strategists Fernanda Trevisan and Ellie Glew, they explore biases stemming from racial, gender, socioeconomic, and cultural prejudices.

Discover the shocking truths uncovered in our study: 
• Gender Bias: Women often receive substandard care compared to men.
• Age Bias: Older patients are frequently given less information and fewer treatment options.
• Racial and Ethnic Bias: Minority ethnic groups face significant disparities in care.
• And more…..

This webinar will explore how these biases influence diagnostic decisions, treatment plans, and patient interactions globally, and their implications for the pharmaceutical industry. Join Fernanda Trevisan, Ellie Glew and Prof. Georgina Charlesworth as they present comprehensive analyses and offer insights into what pharmaceutical companies can do to mitigate these biases. Don’t miss the opportunity to be part of a conversation that could transform healthcare for the better. Secure your spot today!

An Invisible Pandemic

Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, "Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success." Delve deep into the multifaceted landscape of patient engagement, recruitment, and retention challenges and solutions, with a particular focus on the rare disease DADA2. Explore how the synergy between community engagement, trust-building, and interconnected networks among physicians and patients holds the key to unlocking the full potential of clinical trials. Discover actionable insights and transformative strategies that can redefine the trajectory of clinical trial success in rare diseases.

Speakers
Kate Shaw - Founder & CEO, Innovative Trials
Leanne Woehlke - Director, Life Sciences Solutions, TransPerfect
Will Krugman - Marketing & Communications Director, Clinical Research Associates
Chip Chambers - Founder & President, DADA2 Foundation

Uniting Communities for Rare Disease Clinical Trial Success

Join us on 20th May, which marks Clinical Trials Day, as we ask – how can we better understand the patient experience for better clinical trial outcomes?

In our upcoming webinar, we are delighted to be joined by Mark Doyle, Founder, A Life in a Day and Emma Sutcliffe, VP, Head Global Patient Affairs, Ipsen, discuss the transformative journey of clinical trials and the pivotal role patient-centric approaches play in enhancing outcomes.

Join us as Emma shares her insights, shedding light on how a patient-centric focus has become integral to the development and deployment of clinical trials at Ipsen. Delve into practical strategies employed by Emma and her team at Ipsen, supported by immersive learning strategies explored by Mark, to place patients at the forefront of their trials, ultimately elevating the quality and effectiveness of the research.

We will also be diving into the outcomes of employing these strategies, with both speakers sharing insights into the outcomes achievable by better understanding the patient experience and using empathy to drive better outcomes in trials.

Participate in this on-demand webinar to:

• Foster collaboration with patients for enhanced trial outcomes.
• Gain firsthand insights into effectively understanding and addressing patient challenges within trials.
• Explore innovative approaches to design and execute trials with a heightened focus on patient needs.

Clinical Trials: How effective patient engagement shapes key decision making

Recent trends in corporate governance (CG) and M&A are presenting great opportunities for expansion of gaming businesses globally. Increasingly, we are witnessing legalization of gambling and greater regulation in other emerging jurisdictions. All this, at the same time, represents major challenges for transnational gaming companies: How to maintain the highest compliance standards and best industry practices in those jurisdictions that have lax or developing regulations? How can preventive, effective and achievable CG controls be established so as not to incur sanctions that jeopardize the licenses of international major operators in their countries of origin with stricter regulations?

Moderated by Michael Bonner, a Shareholder with Greenberg Traurig, the panelists are:
• Sam Basile, Vice President - North America Gaming & Licensing, GeoComply
• Alfredo Lazcano, Partner, Lazcano Samano
• Stephen Martino, Senior Vice President & Chief Compliance Officer, MGM Resorts International
• Steve Kastner, Vice President of Compliance, PlayDigital, IGT

Ensuring compliance in less regulated jurisdictions

Launching a treatment is a complex process that involves maximizing impact for all stakeholders, from providers to patients. It requires the strategic alignment of each pivotal moment, from regulatory approvals to medical and patient engagement, to launch strategy. Our panel of experts will share valuable insights on the key challenges often faced and solutions on how to ensure your product launch journey is tracked for success.

Ryan Quigley, Chief Operating Officer, Inizio 
Terri Harchar, Managing Director, Nazare (NA), Inizio Engage 
Sese Abhulimen, President Global Decision Optimization, Propensity4 an Inizio Engage Company  
Shauna Aherne, President, Medical Excellence, Medistrava, Inizio Medical 
Brian Stamm, Executive & Product Launch Service Lead, Vynamic, An Inizio Advisory Company 
Will Reese, Chief Innovation Officer, Inizio Evoke 
Scott Briggs, Principal, Putnam an Inizio Advisory Company

Key product launch challenges: creating a successful product launch

In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to pose significant obstacles. As we navigate through the complexities of the current year, experts in the field—namely, Kate Shaw, Leanne Whoehlke, and Will Krugman—will delve into pivotal aspects of patient recruitment and retention challenges. The discussion will intricately explore strategies to augment awareness of clinical trials within the broader public sphere, contemplating innovative approaches to engage with local communities. The focus remains steadfast on ensuring that patient recruitment and retention remain robust throughout the clinical trials course. This discourse promises to illuminate and address critical issues, propelling the clinical trial industry toward enhanced efficacy and patient-centred success.

Kate Shaw - Founder & CEO, Innovative Trials
Leanne Woehlke - Director, Life Sciences Solutions, TransPerfect
Will Krugman - Marketing & Communications Director, Clinical Research Associates

Patient Recruitment & Retention Strategies in the 2024 Clinical Trial Landscape

WorldSkills UK is a world-class skills network focused on raising standards, championing future skills and empowering young people from all backgrounds.  

We have big ambitions to help the next generation, our education system and the economy. From raising self-esteem through to providing opportunities to develop skill levels further and benchmark training delivery. WorldSkills UK tools and resources play a vital role in teaching and learning environments by complementing different approaches to Teaching, Learning and Assessment and bringing learning to life. 

Embedding excellence in technical and vocational education: Teaching and assessment webinar offers an introduction to embed the WorldSkills UK teaching tools and careers education at the right time into the curriculum to help young people grow personally and professionally, developing their technical and employability skills. Including guidance on how to access world-class teacher training through the WorldSkills UK Centre of Excellence and the diverse range of support offered through the Network for Innovation, equipping leaders and teaching practitioners with the knowledge and skills to raise the quality and standards within their provision. 

As a result of embedding world-class practice amongst your learners, they will be equipped to participate in the WorldSkills UK national competitions, using insights from our international competitions to help learners and apprentices be armed with world-class skills employers' demand.

Embedding excellence in technical and vocational education:Teaching & assessment

Play improves the social, emotional and cognitive wellbeing of children and young people. Research suggests that children actually learn best through play, helping them to develop confidence, learn new skills and reduce feelings of stress or anxiety. 

So how can you use play to help neurodivergent children to thrive?

Join Dr Gina Gómez de la Cuesta, Clinical Psychologist and Founder of Play Included®, at 2.00pm (UK time) on Thursday 15 February to learn how you can use collaborative LEGO® play to support the children you work with. 

In this webinar, you will learn: 
• Research into learning through play
• How to support neurodivergent children in their play
• How to identify if LEGO brick based therapy is suitable for the children you work with 

Gina is co-founder of Play Included®, which provides training programmes for education and health professionals to implement the Brick-by-Brick® programme, a neurodiversity-affirming social skills therapy using LEGO bricks that was developed in partnership with, and is officially endorsed by, the LEGO Foundation.

Supporting neurodivergent children through play

15 about brick

*To ensure this webinar caters to your specific interests, we would greatly appreciate it if you could spare just 2 minutes to complete a brief survey after registering. Your input matters to us: https://www.surveymonkey.co.uk/r/DFWLXGM

Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to enrolment issues [1,2], and poor recruitment is a common reason for discontinuation [3]. Of those successfully enrolled, around 30% are likely to drop out [4], which increases costs for sponsors and threatens the viability of the trial itself.

Directly supporting patients from prescreening to study endpoint can help minimize delays and safeguard against early termination, but this can be difficult for hard-pressed sites. Join us as we discuss the most common patient support challenges – as described to us by YOU – and how our new Navigator service can solve them by giving patients a more personalized clinical trial experience and consistent contact, alleviating the burden on sites, and ensuring a sponsor’s study runs efficiently to help accelerate patient access to life-changing treatments.

We will share our insight into why the ‘human touch’ can elevate your in-study patient engagement to the next level and how this permeates through our Navigator service to benefit patients, sites and sponsors. You will also hear from a sponsor that has benefitted from our expertise: the difficulties they faced, the solutions we implemented and the difference we made. And we will share feedback from clinical trial participants about what they think of our support.

Speakers
Chair John Pinching, Editor, PharmaTimes
Laura Burt Director of Operations, Innovative Trials
Kari Reilly Site Operations Lead, Innovative Trials
Helen Andrews Global Clinical Trial Manager, Avillion
Amy Lopez Navigator, Innovative Trials

Solving your biggest patient recruitment and retention challenges

The presence of so-called “grey-market machines as illegal ways to gamble continue to create legal and regulatory issues for the gaming industry, as operators and regulators grapple with how to address a wide range of alternative ways to gamble including illegal slot machines operating as “games of skill.”  In addition, there has been a considerable expansion of “free to play” od co-called “social casino” gaming options in the US markets.  This panel will provide an update on the existing US legal challenges against the gray market and evaluate what regulators and operators can do together to combat the proliferation of “gray” slot machines.  In addition the panel will update how peer-to-peer skill game contests, freemium gaming (a/k/a “social casinos”), and daily fantasy sports variants remain unregulated but have been challenged by civil litigation, and similar issues being faced around the world.

Moderated by Bill Gantz, a Partner with Duane Morris, the panelists include:
• Daron Dorsey, Executive Director, AGEM
• Wulf Hambach, Partner, Hambach & Hambach
• Jeff Morris, Vice President – Public Affairs & Government Relations: PENN Entertainment
• Michael Pollock, Senior Policy Advisor, Spectrum Gaming Group

The Blurred Lines between Legal, Grey and Illegal Ways to Play

Technology is a driving component of the growing online sports betting and iGaming landscape in the U.S. and globally. The rise in uses of technology for operational purposes has also created opportunities to enhance compliance processes. From financial crime detection and anti-fraud measures to exploring data outputs for responsible gaming purposes, technology solutions focus on how an increasingly accessible amount of data can be leveraged for compliance efficiencies and regulatory expectations. How are systems being utilized to capture relevant information? How does the increasing focus on artificial intelligence play into solutions? Hear from industry leaders as they discuss their experiences, uses of technologies and their thoughts on applicability for compliance purposes.  

Moderated by Bob Boyle, Senior Manager at EY, the panelists are:
·         Gabrielle Angle, Director – Government Relations & Licensing at GeoComply
·         Patrick Bland, Chief Technology Officer at Acres Technology
·         Laura McAllister Cox, Chief Compliance Officer, Rush Street Interactive
·         Will Monk, Chief Product Officer, Napier

How Technology is Playing a Significant Role in Gaming Compliance Programs

Putting the patient first has never been higher up the agenda throughout the drug development process, but can we further fine-tune our approach?

Tune into this webinar where we ask:
• How important is early patient engagement to business success.
• How do you ensure the patient voice is as ‘loud’ in later stages
• Whose responsibility is it to ensure the patient voice is heard

Viewers will come out with a deeper understanding of how to best keep the patient voice alive through all stages of drug development.

Keeping the patient voice alive through all stages of drug development

For clinical trial participants, navigating their way through a study can sometimes seem daunting and complicated. Without the right support, around 30% are likely to drop out [1], resulting in extra financial costs for sponsors and potentially placing the future of the trial in jeopardy.

However, sites don’t always have the time and resources available to commit to ongoing and consistent patient engagement. In our upcoming webinar, we will discuss common challenges participants and sites face when it comes to engagement and how our new ‘Navigator’ service is helping to change the game.

Hear how our new patient-centric service benefits patients, sites and sponsors by
ensuring patients get the support they need for the best clinical trial experience possible
decreasing the risk of early trial termination by improving the retention of participants until the very end of a study
reducing the burden on sites by performing a second layer of pre-screening, allowing sites to focus on the science.

Speakers:

Chair - John Pinching, Editor at PharmaTimes
Kari Reilly - Patient Recruitment Manager, Innovative Trials
Kristin Faber - VP of Clinical Trial Patient Recruitment, Spectrum Science
Adel Sepulveda - Patient Navigator, Innovative Trials
TBC - Site

Navigating patients step by step on their clinical trial journey

Marketing surrounding online sports betting is a constantly evolving landscape.  From licensing to the review of advertising language and prohibited phrases, the U.S. has seen many different approaches to this area.  Can the industry successfully regulate itself or will regulators need to step in to police the market?  Are the recent fines levied in Ohio a sign of a changing regulatory perspective?  Will there be a ripple effect in other regulated jurisdictions where previously regulation on marketing was light-touch?  Hear from experts in the industry discuss their thoughts on the future of marketing regulation in the U.S.

Are Marketing Restrictions Coming to the U.S. Markets?

New government targets for primary school student attainment have revived the conversation on how we can use pedagogical strategies and teaching methods to improve outcomes for learners. 

A pedagogical approach is at the core of the International Baccalaureate’s Primary Years Programme (PYP), a student-centric approach to education for children aged four to 11. The inquiry-based, transdisciplinary framework builds conceptual learning and delivers excellent outcomes by providing an education that is engaging, relevant, challenging, and significant. 

Learn more at our free webinar
At 1pm (GMT) on Thursday 16 March, join Education Today and the IB to:
• Learn about pedagogy and the PYP
• Understand how the programme complements the Ofsted framework 
• Hear from school leaders sharing their experiences of how implementing the PYP has improved student outcomes.

Read more about the Primary Years Programme: https://www.ibo.org/programmes/primary-years-programme/

Speakers:

• Jane Tipple, Principal, Bearsted Primary Academy: Jane has delivered both the National Curriculum and the IB PYP in two different academies, which are both authorized IB World Schools and have received successful Ofsted inspections under the new framework. She is passionate about the aspirations, philosophy, and ethos of the IB and its values and the significant impact on learning that the programmes have on all students.

• Peter Fidczuk, Development and Recognition Manager, International Baccalaureate UK and Ireland: Peter supports schools interested in developing IB programmes, engages with UK and Irish universities to develop their understanding of the IB and is the point of contact between the IB and the English Department of Education.

How can primary schools take a pedagogical approach to improvement?

COVID-19 has had a huge impact on how we all think and act. Our working environments may look very different now to the way they did pre-pandemic, and not all the changes have been negative. More flexible work schedules and an acceptance of new ways of thinking have allowed the diversity, equity and inclusion (DE&I) space to take a big step forward. But this is not the full story; some employees feel more isolated and excluded now than ever before.

In this panel debate, speakers will offer an introduction to DE&I in the workplace pre-and post-pandemic, plus a close look at the challenges, opportunities and limitations COVID-19 has created.

Talking points:

• What does ‘diversity’ mean to you and what does/should DE&I look like in the pharma industry?
• How has COVID-19 changed the way we approach DE&I in the workplace?
• Are we doing better in certain sectors of the industry than others?
• Has hybrid working helped or hindered a diverse working environment? Is it less inclusive?
• What is the benefit to the industry if DE&I is delivered successfully? How has COVID-19 furthered this goal?
• How can we inspire the next generation? How can we encourage them into the pharma industry and ultimately push for leadership roles?

Speakers:

Andrés López Castaño, Vaccine Therapeutic Area Lead, Global LGBTQI+ ERG Lead, MSD Switzerland
Tricia Lucas-Clarke, Early Talent Recruitment Inclusion and Diversity Manager, GSK
Noor Shaker, Senior Vice President and General Manager, X-Chem
Sandra Van de Cauter, Innovation Enabling Partner and Diversity and Inclusion Lead, F. Hoffmann-La Roche 
MODERATOR: Marsha N. Ganthier, President, HBA Paris Chapter

Diversity in Pharma: The Impact of COVID-19 on DE&I

Diversity

Covid-19

Equity

Inclusion

Workplace

Workforce

Employees

Employers

Talent

The building and construction community brings together building and construction management professionals. Find relevant webinars and videos on building materials, building construction, renovations and more presented by recognized thought leaders. Join the conversation by participating in live webinars and round table discussions on building and construction trends.

Building and Construction

The research and development community on BrightTALK brings together leading professionals in healthcare, technology and manufacturing to present on current topics in their fields. From big data in healthcare to online forensics training and medical research practices, the community is an exceptional resource for those looking to expand their knowledge. Be part of the conversation by joining the community and participating in interactive live webinars.

Diversity in Pharma: The Impact of COVID-19 on DE&I

Presented by

About this talk

More from this channel